Immunomedics To Present Updated Clinical Results With Solid-Tumor Antibody-Drug Conjugates At Upcoming Conferences
October 22, 2014 at 08:36 AM EDT
Immunomedics, Inc., (Nasdaq: IMMU) today announced that Dr. David M. Goldenberg, Chairman, Chief Scientific Officer, and Chief Medical ...
